FundingWatcher
Home / Investors / Early stage investors / Early stage investors in Basel-Stadt, Switzerland

Early stage investors in Basel-Stadt, Switzerland

Updated 16 Nov 2026

Reset

Venture funds

1 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Novartis Venture Fund
Novartis Venture Fund focuses on novel therapeutics and platforms, with recent investments in Hepalink and FoRx Therapeutics.
Basel, Switzerland
Health care, Biotech Seed, Early stage venture, Late stage venture 27% 2

Table 1. Early stage investors in Basel-Stadt, Switzerland: venture capital and micro VC funds ranked by companies whose Series A and B round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Early stage investors in Basel-Stadt, Switzerland
One-time CSV
  • 20 firms, 17 with a website
  • 11 firm email addresses
  • 12 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-stage-early-stage-investors-basel-stadt-switzerland.csv20 rows × 15 columns
InvestorTypeLocationEmailPhone
Novartis Venture FundCorporate venture armBasel, Switzerland•••@sosei.com877 28•••
Roche Venture FundCorporate venture armBasel, Switzerland•••@roche.com
BioMedPartnersVenture capital firmBasel, Switzerland•••@biomedvc.com+41 61•••
Syngenta VenturesVenture capital firmBasel, Switzerland•••@mriseed.com800-26•••
KickfundVenture capital firmBasel, Switzerland•••@kickfund.ch
Infinitas CapitalFamily officeBasel, Switzerland•••@infinitas-capital.com+41 06•••
MTIP AGPrivate equity firmBasel, Switzerland•••@mtip.ch+41615•••
Gebert Rüf StiftungEntrepreneurship programBasel, Switzerland•••@grstiftung.ch+41061•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

20
Investors
11
With email
12
With phone
3
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Early stage investors in Basel-Stadt, Switzerland

17 of 20, most investments first
17 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Novartis Venture Fund Corporate venture arm, Venture capital firm Basel, Switzerland Health care, Biotech Hepalink, FoRx Therapeutics 2 279 75 77 •••@sosei.com 877 28•••
2 Roche Venture Fund Corporate venture arm Basel, Switzerland Health care, Biotech Cour Pharmaceuticals Development 1 121 15 41 •••@roche.com In the CSV
3 BioMedPartners Venture capital firm Basel, Switzerland Biotech, Health care TOLREMO therapeutics, Topas Therapeutics, Amal Therapeutics 87 29 22 •••@biomedvc.com +41 61••• In the CSV
4 Syngenta Ventures Venture capital firm Basel, Switzerland Fintech, Biotech WeedOut, Tarfin, Agworld 54 9 7 •••@mriseed.com 800-26•••
5 DayOne accelerator Startup accelerator, Startup incubator Basel, Switzerland 53 53 1 In the CSV
6 Kickfund Venture capital firm Basel, Switzerland Health care, Biotech a-metal, Adiposs, NXI Therapeutics 49 8 1 •••@kickfund.ch In the CSV
7 dRx Capital Corporate venture arm, Venture capital firm Basel, Switzerland Biotech, Health care Dopavision 31 4 8 In the CSV
8 Helvetia Venture Fund Venture capital firm Basel, Switzerland Fintech, Health care FAAREN Group GmbH, INKI.TECH, Urban Connect 30 16 3 +41058••• In the CSV
9 Infinitas Capital Family office, Venture capital firm Basel, Switzerland Education, Hardware einwert, Storypod, Olsam Group 26 4 4 •••@infinitas-capital.com +41 06••• In the CSV
10 MTIP AG Private equity firm Basel, Switzerland Health care, Artificial intelligence NitiNotes, Hexarad, Apricity 22 13 4 •••@mtip.ch +41615••• In the CSV
11 Gebert Rüf Stiftung Entrepreneurship program, Government investment office Basel, Switzerland Biotech, Health care NXI Therapeutics, Hemotune, POLYNEURON 22 11 0 •••@grstiftung.ch +41061••• In the CSV
12 AVANTECA Partners Private equity firm Basel, Switzerland 7 2 0 In the CSV
13 EVA Basel Entrepreneurship program, Venture capital firm Basel, Switzerland Health care, Biotech Inthera Bioscience, AOT - Advanced Osteotomy Tools 6 3 2 •••@eva-basel.ch +41612••• In the CSV
14 New Energies Invest Venture capital firm Basel, Switzerland 3 1 2 •••@newenergies.ch +41 61•••
15 CPV / CAP Pension Fund Coop. Pension fund Basel, Switzerland 2 1 0 +41 61••• In the CSV
16 Erfindungs Verwertung Venture capital firm Basel, Switzerland 1 0 0 +41 61••• In the CSV
17 Around Capital Family office, Startup incubator Basel, Switzerland 0 0 0 •••@aroundcapital.com In the CSV

Table 2. Early stage investors in Basel-Stadt, Switzerland: the first 17 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 20.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Novartis Venture Fund Basel, Switzerland 2 20 Hepalink, FoRx Therapeutics
2 Roche Venture Fund Basel, Switzerland 1 3 Cour Pharmaceuticals Development
3 Wecken & Cie. Basel, Switzerland 1 6 happyhotel

Table 3. Early stage investors in Basel-Stadt, Switzerland: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Cour Pharmaceuticals Development Cour Pharmaceuticals Development develops nanoparticle technology to reset immune systems in multiple sclerosis patients. Biotech Skokie, United States Series B $50.0M 2026-06-18 $185.5M Roche Venture Fund 51 to 100 2015
happyhotel happyhotel offers an AI sales manager that automates the sales process for hotels. Artificial intelligence Offenburg, Germany Series A $7.7M 2026-02-19 $7.7M Wecken & Cie. 11 to 50 2019
FoRx Therapeutics FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. Biotech Basel, Switzerland Series A $50.0M 2025-12-18 $109.4M Novartis Venture Fund 11 to 50 2019

Table 4. Early stage investors in Basel-Stadt, Switzerland: the 3 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Health care 41 65%
Biotech 34 54%
Software 19 30%
Artificial intelligence 6 10%
Hardware 4 6%
Fintech 3 5%
Commerce 2 3%
Education 1 2%

Table 5. Early stage investors in Basel-Stadt, Switzerland: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Early stage investors in Basel-Stadt, Switzerland by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 2 12%
2010s 5 29%
2000s 4 24%
1990s 4 24%
1900s 1 6%
1850s 1 6%

Table 7. Early stage investors in Basel-Stadt, Switzerland by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many early stage investors in Basel-Stadt, Switzerland are on the list?
20, in the file dated 16 November 2026. 3 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
11 of the 20 carry an email address in the download and 12 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 20 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 20 rows, 11 firm email addresses and 12 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 8 of the 11 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Early stage investors in Basel-Stadt, Switzerland: 20 rows, CSV, $29 one-time.

At once: the CSV with 20 rows, 11 firm email addresses and 12 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 8 of the 11 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Other stages in Basel-Stadt

Early stage investors elsewhere

Cite: FundingWatcher, 20 early stage investors in Basel-Stadt, Switzerland, 16 November 2026. https://fundingwatcher.com/investors/stage/early-stage-investors/basel-stadt-switzerland/